Statistics
Publications
33
Citations
3.1K
H-Index
26
Active since
1982
Paweł Dobrzański is an author at Bristol-Myers Squibb (United States) specializing in medicine, cell biology, and cell signaling.
Publications per year
1982–2022
33
33
Antiangiogenic and Antitumor Efficacy of EphA2 Receptor Antagonist
Paweł Dobrzański, Kathryn Hunter, Susan Jones‐Bolin et al. · Cancer Research · 2004 · 159 citations
Rows per page
1–5 of 33